- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.60 Å
- Oligo State
- hetero-1-1-1-1-1-1-1-1-1-1-1-1-1-mer
- Ligands
- 2 x HEA: HEME-A(Non-covalent)
- 1 x CU: COPPER (II) ION(Non-covalent)
- 1 x MG: MAGNESIUM ION(Non-covalent)
- 1 x NA: SODIUM ION(Non-functional Binders)
- 1 x CYN: CYANIDE ION(Non-covalent)
- 4 x PGV: (1R)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL (11E)-OCTADEC-11-ENOATE(Non-covalent)
PGV.7: 12 residues within 4Å:- Chain A: N.406, T.408, W.409
- Chain D: A.81, F.84
- Chain K: F.4, H.5
- Chain M: P.12, Q.15, A.16
- Ligands: EDO.35, EDO.169
17 PLIP interactions:5 interactions with chain M, 5 interactions with chain A, 3 interactions with chain K, 4 interactions with chain D- Hydrophobic interactions: M:P.12, M:Q.15, M:A.16, A:T.408, A:W.409, A:W.409, A:W.409, K:F.4, K:F.4, D:A.81, D:F.84, D:F.84, D:F.84
- Water bridges: M:A.3, M:K.4
- Hydrogen bonds: A:T.408
- Salt bridges: K:H.5
PGV.8: 28 residues within 4Å:- Chain A: F.94, P.95, R.96, M.97, F.148, H.151, L.152, I.158, P.200
- Chain C: H.7, V.9, G.18, A.22, T.26, N.48, T.51, M.52, W.55, W.56, V.59, E.62, H.69, L.77, G.80, F.84, S.87, E.88
- Ligands: PEK.64
19 PLIP interactions:11 interactions with chain C, 8 interactions with chain A- Hydrophobic interactions: C:A.22, C:T.26, C:T.51, C:W.55, C:W.55, C:W.55, C:W.56, C:F.84, C:F.84, C:F.84, A:F.148, A:L.152, A:I.158, A:P.200
- Hydrogen bonds: C:W.55, A:R.96, A:R.96, A:M.97
- Salt bridges: A:R.96
PGV.66: 23 residues within 4Å:- Chain C: M.49, M.52, W.56, V.59, I.60, S.63, T.64, H.69, M.81, F.84, H.205, I.208, T.211, F.212, R.219, H.224, F.225, T.226, H.229, H.230, F.231, G.232
- Ligands: CDL.68
27 PLIP interactions:25 interactions with chain C, 2 interactions with chain F- Hydrophobic interactions: C:W.56, C:W.56, C:W.56, C:W.56, C:W.56, C:W.56, C:I.60, C:F.84, C:I.208, C:I.208, C:T.211, C:F.212, C:F.212, C:F.212
- Hydrogen bonds: C:S.63, C:R.219, C:F.231, C:G.232
- Water bridges: C:S.63, C:R.219, C:H.229, C:H.229, F:Q.12, F:E.17
- Salt bridges: C:R.219, C:R.219, C:H.229
PGV.67: 14 residues within 4Å:- Chain A: F.237, D.298
- Chain C: T.93, W.97, Y.100, H.101, L.104, A.105
- Chain H: N.18
- Ligands: EDO.16, CHD.62, EDO.80, EDO.137, EDO.139
8 PLIP interactions:5 interactions with chain C, 2 interactions with chain A, 1 interactions with chain H- Hydrophobic interactions: C:T.93, C:W.97, C:W.97, C:L.104, A:F.237, A:F.237
- Salt bridges: C:H.101
- Hydrogen bonds: H:N.18
- 142 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.9: 6 residues within 4Å:- Chain A: D.221, P.222, A.223
- Ligands: EDO.33, EDO.43, EDO.72
Ligand excluded by PLIPEDO.10: 1 residues within 4Å:- Chain A: F.2
Ligand excluded by PLIPEDO.11: 8 residues within 4Å:- Chain A: Y.260, Y.261, V.394, H.395, P.398, W.494
- Chain M: I.1
- Ligands: EDO.172
Ligand excluded by PLIPEDO.12: 5 residues within 4Å:- Chain A: K.265, T.489
- Chain F: I.70, P.83, S.84
Ligand excluded by PLIPEDO.13: 6 residues within 4Å:- Chain A: H.256, T.259, K.265, T.490, N.491
- Ligands: EDO.124
Ligand excluded by PLIPEDO.14: 7 residues within 4Å:- Chain A: G.269, Y.270, M.271, G.272
- Chain B: A.58, E.62
- Ligands: CHD.42
Ligand excluded by PLIPEDO.15: 5 residues within 4Å:- Chain A: L.33, A.60, S.116
- Chain L: I.38, V.39
Ligand excluded by PLIPEDO.16: 2 residues within 4Å:- Chain A: Y.304
- Ligands: PGV.67
Ligand excluded by PLIPEDO.17: 4 residues within 4Å:- Chain A: Q.52, A.137, H.138, A.139
Ligand excluded by PLIPEDO.18: 7 residues within 4Å:- Chain A: E.507
- Chain C: T.3
- Chain F: P.30, N.32, P.50, R.56, H.94
Ligand excluded by PLIPEDO.19: 10 residues within 4Å:- Chain A: R.5, N.11, K.13, D.14, W.81, P.499, P.500, Y.502
- Chain L: N.9
- Ligands: EDO.165
Ligand excluded by PLIPEDO.20: 7 residues within 4Å:- Chain A: F.505, E.507, P.508, T.509
- Chain F: R.56, I.57, W.73
Ligand excluded by PLIPEDO.21: 7 residues within 4Å:- Chain A: K.265, E.266
- Chain B: T.55
- Chain F: N.66, T.68, I.70, S.84
Ligand excluded by PLIPEDO.22: 3 residues within 4Å:- Chain A: P.501, H.503, E.506
Ligand excluded by PLIPEDO.23: 7 residues within 4Å:- Chain A: G.45, T.46
- Ligands: EDO.27, EDO.47, EDO.58, EDO.96, EDO.168
Ligand excluded by PLIPEDO.24: 3 residues within 4Å:- Chain A: W.103
- Ligands: EDO.79, TGL.156
Ligand excluded by PLIPEDO.25: 4 residues within 4Å:- Chain A: F.418, N.422, M.423
- Ligands: TGL.38
Ligand excluded by PLIPEDO.26: 4 residues within 4Å:- Chain A: H.328
- Chain I: A.14, L.17
- Ligands: PSC.41
Ligand excluded by PLIPEDO.27: 10 residues within 4Å:- Chain A: Q.43, P.44, G.45, T.46, L.47
- Chain D: P.103, I.104, P.105
- Ligands: EDO.23, EDO.96
Ligand excluded by PLIPEDO.28: 5 residues within 4Å:- Chain A: P.106, P.107, L.110
- Chain C: L.20
- Ligands: EDO.79
Ligand excluded by PLIPEDO.29: 7 residues within 4Å:- Chain A: Y.19, M.71, P.72, S.101, L.105, S.156, S.157
Ligand excluded by PLIPEDO.30: 5 residues within 4Å:- Chain A: N.170, K.172, P.173, P.174, M.176
Ligand excluded by PLIPEDO.31: 5 residues within 4Å:- Chain A: W.334, S.335, D.407, K.411
- Ligands: EDO.172
Ligand excluded by PLIPEDO.32: 5 residues within 4Å:- Chain A: V.485, D.486, L.487, T.488, T.489
Ligand excluded by PLIPEDO.33: 4 residues within 4Å:- Chain A: P.131, D.221, P.222
- Ligands: EDO.9
Ligand excluded by PLIPEDO.34: 3 residues within 4Å:- Chain A: L.136, A.137
- Chain B: Q.103
Ligand excluded by PLIPEDO.35: 6 residues within 4Å:- Chain A: T.404, D.407
- Chain M: I.1, A.3
- Ligands: PGV.7, EDO.172
Ligand excluded by PLIPEDO.36: 6 residues within 4Å:- Chain A: L.483, V.485, W.494, G.497, C.498
- Chain D: Y.8
Ligand excluded by PLIPEDO.37: 7 residues within 4Å:- Chain A: M.390, H.413, M.417, A.464, V.465, M.468
- Ligands: HEA.1
Ligand excluded by PLIPEDO.43: 5 residues within 4Å:- Chain B: E.157, P.176
- Ligands: EDO.9, EDO.72, EDO.138
Ligand excluded by PLIPEDO.44: 3 residues within 4Å:- Chain B: H.102, E.157, D.158
Ligand excluded by PLIPEDO.45: 7 residues within 4Å:- Chain A: Y.447
- Chain B: M.1, A.2, Q.10, L.136, P.166, Y.193
Ligand excluded by PLIPEDO.46: 5 residues within 4Å:- Chain B: P.15, E.18, M.185, S.187
- Chain I: Y.51
Ligand excluded by PLIPEDO.47: 4 residues within 4Å:- Chain B: T.125, L.135
- Ligands: EDO.23, EDO.58
Ligand excluded by PLIPEDO.48: 5 residues within 4Å:- Chain B: M.87, L.170, T.182, T.183
- Ligands: EDO.59
Ligand excluded by PLIPEDO.49: 7 residues within 4Å:- Chain B: Y.3, Q.6, L.7, G.8, F.9
- Ligands: TGL.38, EDO.98
Ligand excluded by PLIPEDO.50: 6 residues within 4Å:- Chain B: N.92, P.93
- Chain H: Q.6, T.7, A.8, P.9
Ligand excluded by PLIPEDO.51: 4 residues within 4Å:- Chain B: W.104, M.122, N.203, F.206
Ligand excluded by PLIPEDO.52: 7 residues within 4Å:- Chain B: T.111, D.112, Y.113, E.114, D.115
- Chain H: R.52, K.55
Ligand excluded by PLIPEDO.53: 8 residues within 4Å:- Chain B: S.94, L.95, Y.113, M.148, L.216, F.219
- Chain H: Q.6
- Ligands: EDO.54
Ligand excluded by PLIPEDO.54: 5 residues within 4Å:- Chain B: Y.113, F.219, E.220, S.223
- Ligands: EDO.53
Ligand excluded by PLIPEDO.55: 4 residues within 4Å:- Chain B: S.36, L.39, Y.40
- Ligands: TGL.38
Ligand excluded by PLIPEDO.56: 4 residues within 4Å:- Chain B: T.63, T.66, I.67
- Ligands: CHD.42
Ligand excluded by PLIPEDO.57: 4 residues within 4Å:- Chain B: Y.40, S.43, T.47
- Ligands: TGL.39
Ligand excluded by PLIPEDO.58: 6 residues within 4Å:- Chain B: T.125, R.134
- Chain D: P.105
- Ligands: EDO.23, EDO.47, EDO.96
Ligand excluded by PLIPEDO.59: 8 residues within 4Å:- Chain B: S.14, P.15, I.16, L.168, T.183, L.184, M.185
- Ligands: EDO.48
Ligand excluded by PLIPEDO.60: 2 residues within 4Å:- Chain B: E.147
- Ligands: EDO.61
Ligand excluded by PLIPEDO.61: 5 residues within 4Å:- Chain B: M.146, E.147, P.215, L.216
- Ligands: EDO.60
Ligand excluded by PLIPEDO.72: 8 residues within 4Å:- Chain A: P.222
- Chain B: G.177
- Chain C: E.109
- Chain H: W.62
- Ligands: EDO.9, EDO.43, EDO.87, EDO.138
Ligand excluded by PLIPEDO.73: 3 residues within 4Å:- Chain C: S.103, W.114, W.257
Ligand excluded by PLIPEDO.74: 5 residues within 4Å:- Chain C: L.136, G.139, T.143
- Chain G: W.16
- Ligands: EDO.84
Ligand excluded by PLIPEDO.75: 2 residues within 4Å:- Chain C: F.249
- Ligands: CDL.131
Ligand excluded by PLIPEDO.76: 4 residues within 4Å:- Chain C: L.125, Y.251, W.256
- Ligands: CDL.131
Ligand excluded by PLIPEDO.77: 3 residues within 4Å:- Chain C: H.241
- Ligands: PEK.63, EDO.83
Ligand excluded by PLIPEDO.78: 5 residues within 4Å:- Chain C: N.10, Q.66, H.68
- Ligands: EDO.85, EDO.149
Ligand excluded by PLIPEDO.79: 3 residues within 4Å:- Chain A: W.103
- Ligands: EDO.24, EDO.28
Ligand excluded by PLIPEDO.80: 4 residues within 4Å:- Chain C: T.93, W.97
- Ligands: PEK.63, PGV.67
Ligand excluded by PLIPEDO.81: 3 residues within 4Å:- Chain C: H.147
- Chain G: T.11, W.16
Ligand excluded by PLIPEDO.82: 5 residues within 4Å:- Chain C: H.1, Q.2, H.68
- Chain F: L.16
- Ligands: EDO.85
Ligand excluded by PLIPEDO.83: 4 residues within 4Å:- Chain C: E.234, W.238
- Ligands: PEK.63, EDO.77
Ligand excluded by PLIPEDO.84: 3 residues within 4Å:- Chain C: D.244, V.245
- Ligands: EDO.74
Ligand excluded by PLIPEDO.85: 5 residues within 4Å:- Chain C: Q.66, H.68
- Chain J: Q.13
- Ligands: EDO.78, EDO.82
Ligand excluded by PLIPEDO.86: 3 residues within 4Å:- Chain C: P.71, A.72
- Chain F: I.33
Ligand excluded by PLIPEDO.87: 6 residues within 4Å:- Chain B: G.177
- Chain C: E.109
- Chain H: W.62, W.66
- Ligands: EDO.72, EDO.138
Ligand excluded by PLIPEDO.88: 4 residues within 4Å:- Chain D: I.94, H.98, Y.99
- Ligands: EDO.94
Ligand excluded by PLIPEDO.89: 4 residues within 4Å:- Chain A: I.332, W.334
- Chain D: R.70
- Ligands: TGL.39
Ligand excluded by PLIPEDO.90: 6 residues within 4Å:- Chain B: P.130
- Chain D: E.109, E.111, W.112, K.115
- Ligands: EDO.91
Ligand excluded by PLIPEDO.91: 3 residues within 4Å:- Chain D: E.111, K.115
- Ligands: EDO.90
Ligand excluded by PLIPEDO.92: 6 residues within 4Å:- Chain D: P.22, D.23, V.24, A.25, K.60
- Chain E: R.26
Ligand excluded by PLIPEDO.93: 6 residues within 4Å:- Chain D: K.118, L.121, D.122, W.135
- Chain K: P.45
- Ligands: EDO.106
Ligand excluded by PLIPEDO.94: 2 residues within 4Å:- Chain D: L.91
- Ligands: EDO.88
Ligand excluded by PLIPEDO.95: 8 residues within 4Å:- Chain D: K.124, P.127, S.132, A.133, Y.137
- Chain I: F.50
- Ligands: EDO.143, EDO.146
Ligand excluded by PLIPEDO.96: 6 residues within 4Å:- Chain D: P.103, I.104, P.105
- Ligands: EDO.23, EDO.27, EDO.58
Ligand excluded by PLIPEDO.97: 6 residues within 4Å:- Chain D: F.84, F.85, F.88
- Chain M: S.20, F.23
- Ligands: EDO.171
Ligand excluded by PLIPEDO.98: 5 residues within 4Å:- Chain D: Q.129, K.134
- Chain I: R.43
- Ligands: TGL.38, EDO.49
Ligand excluded by PLIPEDO.99: 3 residues within 4Å:- Chain D: R.58, E.67
- Ligands: EDO.100
Ligand excluded by PLIPEDO.100: 1 residues within 4Å:- Ligands: EDO.99
Ligand excluded by PLIPEDO.101: 3 residues within 4Å:- Chain D: D.15, R.16, M.68
Ligand excluded by PLIPEDO.102: 5 residues within 4Å:- Chain D: L.37, D.51, E.52, E.55
- Ligands: EDO.105
Ligand excluded by PLIPEDO.103: 6 residues within 4Å:- Chain D: A.25, V.27, K.28, L.30, K.38, L.59
Ligand excluded by PLIPEDO.104: 4 residues within 4Å:- Chain D: K.42, A.43, S.44
- Chain E: R.52
Ligand excluded by PLIPEDO.105: 4 residues within 4Å:- Chain D: S.33, Q.34, E.55
- Ligands: EDO.102
Ligand excluded by PLIPEDO.106: 5 residues within 4Å:- Chain D: D.122, K.124, Y.137
- Chain I: E.62
- Ligands: EDO.93
Ligand excluded by PLIPEDO.107: 5 residues within 4Å:- Chain D: Y.13, V.14, D.15, K.62
- Chain M: T.2
Ligand excluded by PLIPEDO.108: 3 residues within 4Å:- Chain D: K.134
- Chain K: S.38, V.40
Ligand excluded by PLIPEDO.109: 4 residues within 4Å:- Chain E: Y.14, K.17, I.20, E.24
Ligand excluded by PLIPEDO.110: 3 residues within 4Å:- Chain E: R.49, R.52, R.53
Ligand excluded by PLIPEDO.111: 5 residues within 4Å:- Chain D: K.53
- Chain E: N.90, G.93, I.94, S.95
Ligand excluded by PLIPEDO.112: 5 residues within 4Å:- Chain E: D.19, I.20, D.21, L.54
- Ligands: EDO.113
Ligand excluded by PLIPEDO.113: 5 residues within 4Å:- Chain E: K.17, D.19, D.21, E.24
- Ligands: EDO.112
Ligand excluded by PLIPEDO.114: 4 residues within 4Å:- Chain E: R.10, W.11, Y.14
- Ligands: EDO.121
Ligand excluded by PLIPEDO.115: 4 residues within 4Å:- Chain E: Y.78, P.79, I.82, E.98
Ligand excluded by PLIPEDO.116: 2 residues within 4Å:- Chain E: E.98, E.99
Ligand excluded by PLIPEDO.117: 7 residues within 4Å:- Chain D: Y.19, D.23
- Chain E: W.23, R.26, K.27, N.30
- Chain F: P.83
Ligand excluded by PLIPEDO.118: 6 residues within 4Å:- Chain B: T.51
- Chain D: R.17, D.18
- Chain E: V.66, D.69, K.70
Ligand excluded by PLIPEDO.119: 3 residues within 4Å:- Chain E: R.53, L.54, N.55
Ligand excluded by PLIPEDO.120: 3 residues within 4Å:- Chain E: N.16, P.18, R.53
Ligand excluded by PLIPEDO.121: 5 residues within 4Å:- Chain E: W.11, Y.14, K.27, T.31
- Ligands: EDO.114
Ligand excluded by PLIPEDO.123: 4 residues within 4Å:- Chain C: H.229
- Chain F: D.9, E.17
- Ligands: EDO.129
Ligand excluded by PLIPEDO.124: 7 residues within 4Å:- Chain A: T.489, T.490
- Chain F: S.67, T.68, V.69, W.71
- Ligands: EDO.13
Ligand excluded by PLIPEDO.125: 6 residues within 4Å:- Chain A: Y.510
- Chain F: P.36, K.37, T.39, N.47, L.48
Ligand excluded by PLIPEDO.126: 4 residues within 4Å:- Chain F: F.72, Q.80, R.81, P.83
Ligand excluded by PLIPEDO.127: 6 residues within 4Å:- Chain F: T.8, D.9, E.10, M.21, R.25
- Ligands: EDO.129
Ligand excluded by PLIPEDO.128: 6 residues within 4Å:- Chain F: V.20, A.24, Q.28, D.29, I.33, L.34
Ligand excluded by PLIPEDO.129: 5 residues within 4Å:- Chain C: N.228
- Chain F: D.9, M.21
- Ligands: EDO.123, EDO.127
Ligand excluded by PLIPEDO.130: 8 residues within 4Å:- Chain A: P.174, T.509, Y.510, V.511
- Chain F: N.32, L.34, P.36, R.56
Ligand excluded by PLIPEDO.133: 6 residues within 4Å:- Chain C: G.118
- Chain G: A.46, F.47, I.48, L.53, R.54
Ligand excluded by PLIPEDO.134: 6 residues within 4Å:- Chain C: W.32, F.33
- Chain G: K.58, P.59, F.60, S.61
Ligand excluded by PLIPEDO.135: 2 residues within 4Å:- Chain G: A.1, A.3
Ligand excluded by PLIPEDO.136: 5 residues within 4Å:- Chain C: T.117
- Chain G: Y.50
- Chain H: F.75, P.76, G.77
Ligand excluded by PLIPEDO.137: 6 residues within 4Å:- Chain H: F.14, P.15, N.16, N.18, R.21
- Ligands: PGV.67
Ligand excluded by PLIPEDO.138: 5 residues within 4Å:- Chain H: S.61, T.65
- Ligands: EDO.43, EDO.72, EDO.87
Ligand excluded by PLIPEDO.139: 7 residues within 4Å:- Chain A: D.227
- Chain B: G.177, R.178
- Chain C: T.107
- Chain H: N.18, T.20
- Ligands: PGV.67
Ligand excluded by PLIPEDO.141: 2 residues within 4Å:- Chain I: Q.70, S.71
Ligand excluded by PLIPEDO.142: 5 residues within 4Å:- Chain I: Y.54, D.55, D.59, E.62
- Ligands: EDO.146
Ligand excluded by PLIP
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.60 Å
- Oligo State
- hetero-1-1-1-1-1-1-1-1-1-1-1-1-1-mer
- Ligands
- 2 x HEA: HEME-A(Non-covalent)
- 1 x CU: COPPER (II) ION(Non-covalent)
- 1 x MG: MAGNESIUM ION(Non-covalent)
- 1 x NA: SODIUM ION(Non-functional Binders)
- 1 x CYN: CYANIDE ION(Non-covalent)
- 4 x PGV: (1R)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL (11E)-OCTADEC-11-ENOATE(Non-covalent)
- 142 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)